A rare case of left ventricular lead stabilization utilizing a coronary stent placement during CRT-D implantation
Journal Title: The European Research Journal - Year 2019, Vol 5, Issue 2
Abstract
During cardiac resynchronization therapy implantation, left ventricular lead placement involves transvenous placement of leads via the coronary sinus and into a tributary branch. At present, the most widely used method for left ventricular (LV) lead placement involves a transvenous LV lead placement via the coronary sinus into a tributary branch. Lead dislodgement is a common cause for reoperation. We describe a case where a coronary stent was placed to stabilize the lead against the vessel wall.
Authors and Affiliations
Deepak Agarwal, Aman Makhija, Arun Mohanty, Raja Ram Mantri
Keywords
Related Articles
- EP ID EP502967
- DOI 10.18621/eurj.397159
- Views 108
- Downloads 0
Experience of thrombotic microangiopathy unresponsive to therapeutic apheresis
No abstract available.
Biometric and intraocular pressure changes after Nd:YAG laser capsulotomy
Objective. We aimed to investigate the influences of Nd:YAG (neodymium-doped yttrium aluminum garnet) laser capsulotomy on ocular biometric parameters. Methods. In this prospective study, 117 eyes of 117 pseudophakic pat...
Endolaryngeal diode laser surgery for early glottic carcinomas involving anterior commissure
Objective. In this study, we present the results of endolaryngeal diode laser surgery in patients with an early stage laryngeal carcinoma involving the anterior commissure (AC). Methods. A total of 108 patients (103 male...
Clinical and pathological evaluation of histopathological subtypes in patients with non-Hodgkin’s lymphoma
Objectives. Non-Hodgkin Lymphomas (NHLs) are tumours of the lymphoid system which originate from lymph nodes or extranodal lymphatic tissue. Since they represent a heterogeneous group of diseases, it is very important to...
Effects of a single dose 20 mg tadalafil on resistive index value of prostate zones
Objectives: Although there are several studies addressing the efficacy of phosphodiesterase type 5 inhibitors for the management of benign prostatic hyperplasia-lower urinary tract symptoms (BPH-LUTS), unfortunately, the...